Related Experiment Video

Updated: Jun 4, 2026

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
09:04

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat

Published on: February 27, 2014

Trace elements and vitamins at diagnosis in pediatric-onset inflammatory bowel disease

Sheena K Sikora1, Donald Spady, Connie Prosser

  • 1University of Alberta, Edmonton, Alberta, Canada.

Clinical Pediatrics
|February 15, 2011
PubMed

Insights

Newly diagnosed children with inflammatory bowel disease (IBD) have significantly lower serum zinc levels compared to healthy children. This finding highlights potential nutritional deficiencies in pediatric IBD patients at diagnosis.

Area of Science:

  • Pediatric Gastroenterology
  • Nutritional Science
  • Inflammatory Bowel Disease Research

Background:

  • Inflammatory Bowel Disease (IBD) encompasses chronic conditions like Crohn's disease and ulcerative colitis.
  • Nutritional status is a critical concern in pediatric IBD management.
  • Specific vitamin and mineral deficiencies may be present at diagnosis.

Purpose of the Study:

  • To compare serum vitamin and mineral levels in children diagnosed with IBD versus a control group.
  • To identify potential nutritional biomarkers in newly diagnosed pediatric IBD patients.

Main Methods:

  • Retrospective cohort study design.
  • Analysis of serum levels of key nutrients including iron, zinc, folate, selenium, vitamin B12, vitamin A, and vitamin E.
  • Comparison between 154 children with IBD and 64 age- and gender-matched controls.

Main Results:

  • Children with IBD showed significantly lower serum zinc levels at diagnosis compared to controls (P < .001).
  • Mean serum zinc levels were 8.74 ± 2.08 µmol/L for Crohn's disease and 11.33 ± 4.16 µmol/L for ulcerative colitis, versus 11.49 ± 1.63 µmol/L for controls.
  • The study included 154 IBD patients (mean age 11.27 years) and 64 controls.

Conclusions:

  • Serum zinc levels are significantly lower in newly diagnosed children with IBD compared to those without the condition.
  • This suggests zinc deficiency may be an early indicator or consequence of pediatric IBD.
  • Further research into nutritional interventions for pediatric IBD is warranted.
Abstract

More Related Videos

Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation07:05

Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation

Published on: December 15, 2017

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis08:58

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Published on: January 5, 2017

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...